-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VndGCaN320wdrPxZrsB5IWmw2p6jiZ09oCh65U0IhkCZVsxgPKQa7efqA/jaD7CI 4uodtukjCggngXXThXWubw== 0001015402-04-003032.txt : 20040728 0001015402-04-003032.hdr.sgml : 20040728 20040726185034 ACCESSION NUMBER: 0001015402-04-003032 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040727 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MANTEIA SA CENTRAL INDEX KEY: 0001284289 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1267 ZONE INDUSTRIELLE CITY: COINSINS STATE: V8 ZIP: 00000 BUSINESS PHONE: 41223545800 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LYNX THERAPEUTICS INC CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-45671 FILM NUMBER: 04931871 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 SC 13G/A 1 doc1.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13D-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 1)* LYNX THERAPEUTICS, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.01 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 551812 30 8 - -------------------------------------------------------------------------------- (CUSIP Number) June 1, 2004 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 - ------------------------- ------------------------------- | CUSIP NO. 551812 30 8 | 13G | PAGE 2---- of ------5 PAGES | - ------------------------- ------------------------------- - -------------------------------------------------------------------------------- | 1 | Names of Reporting Persons/I.R.S. Identification Nos. of | | | Above Persons (Entities Only) | | | | | | Manteia SA | - -------------------------------------------------------------------------------- | 2 | Check the Appropriate Box if a Member of a Group (a) [ ]| | | (See Instructions) (b) [ ]| - -------------------------------------------------------------------------------- | 3 | SEC Use Only | | | | - -------------------------------------------------------------------------------- | 4 | Citizenship or Place of Organization | | | | | | Switzerland | - -------------------------------------------------------------------------------- | Number of | 5 | Sole Voting Power | | | | | | | | 0 | | |------------------------------------------------------------- | Shares | 6 | Shared Voting Power | | | | | | | | 0 | | |------------------------------------------------------------- | Beneficially | 7 | Sole Dispositive Power | | | | | | | | 0 | | |------------------------------------------------------------- | Owned by | 8 | Shared Dispositive Power | | | | | | Each | | 0 | | | | | | Reporting | | | | | | | | Person With | | | - -------------------------------------------------------------------------------- | 9 | Aggregate Amount Beneficially Owned by Each Reporting | | | Person | | | | | | 0 | - -------------------------------------------------------------------------------- | 10 | Check if the Aggregate Amount in Row (9) Excludes Certain | | | Shares [ ] (See Instructions) | | | | - -------------------------------------------------------------------------------- | 11 | Percent of Class Represented by Amount in Row (9) | | | | | | 0.0% | - -------------------------------------------------------------------------------- | 12 | Type of Reporting Person (See Instructions) | | | | | | CO | - -------------------------------------------------------------------------------- - ------------------------- ------------------------------- | CUSIP NO. 551812 30 8 | 13G | PAGE 3---- of ------5 PAGES | - ------------------------- ------------------------------- ITEM 1(a). NAME OF ISSUER: Lynx Therapeutics, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 25861 Industrial Boulevard Hayward, CA 94545 ITEM 2(a). NAME OF PERSON FILING: Manteia SA ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: Manteia SA Zone Industrielle 1267 Coinsins Switzerland ITEM 2(c). CITIZENSHIP: A stock company organized under the laws of Switzerland. ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, par value $0.01 per share ITEM 2(e). CUSIP NUMBER: 551812 30 8 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: Not applicable. ITEM 4. OWNERSHIP. (a) Amount beneficially owned: 0 (b) Percent of class: 0.0% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 0 - ------------------------- ------------------------------- | CUSIP NO. 551812 30 8 | 13G | PAGE 4---- of ------5 PAGES | - ------------------------- ------------------------------- ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ x ]. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. ITEM 10. CERTIFICATIONS. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. - ------------------------- ------------------------------- | CUSIP NO. 551812 30 8 | 13G | PAGE 5---- of ------5 PAGES | - ------------------------- ------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: 12 July 2004 MANTEIA SA /s/ Francois Naef ---------------------------------------- By: Francois Naef Title: Director -----END PRIVACY-ENHANCED MESSAGE-----